·        Grants totalling in excess of £2.2M awarded from two industry leading innovation funds ·   &nb...

·       Drug Discovery 2026 returns to ExCeL London from 14–15 October to celebrate 20 years of collaboration and inclusion ...

T-CURX leverages Pantherna's deep expertise and proprietary technologies in LNP-based delivery of mRNA and DNA vectors to advance T-CURX innovative in vivo CAR-...

Quarterly revenue growth up 135% year-on-year, with total revenues passing ₹2000 crore for the first time Neuland Laboratories, a global contract dev...

The results point to new directions for the expansion of clinical applications, particularly in tumor and metabolic diseases HYD LLC., the organiser of th...

Version 1.0 strengthens the fast, confident HDX-MS analysis experience with workflow-focused enhancements, optimised performance, and improved support for mutant...

ProBioGen today announced the launch of AGE1.CR.ReX®, its next-generation avian designer cell line for stable, high-titre poxvirus production and rapid generatio...

Too many biotechs rely too narrowly on large CDMOs and engage too late, increasing risk of delays, scope creep and cost overruns by up to 40% Ahead of nex...

Pharmaceutical service provider receives prestigious management award for the seventh year in a row Family-owned company once again excels in all four key bu...

The US Food and Drug Administration (FDA) has recently granted accelerated approval to Gilead Sciences' antiviral, Hepcludex (bulevirtide-gmod), for the treatmen...